Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02242201 · ClinicalTrials.gov registry record · Phase 4
Total Hip Arthroplasty (THA) Lumbar Plexus Verses Periarticular
A Phase 4 study of Total Hip Arthroplasty, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 165
- Enrollment target
- 1
- Study location
NCT02242201: Completed Phase 4 study of Total Hip Arthroplasty, sponsored by Mayo Clinic.
NCT02242201 is a Phase 4 study of Total Hip Arthroplasty that has completed, run by Mayo Clinic. The registered enrollment target is 165 participants, above the 131-participant average among 12 other Total Hip Arthroplasty trials with a reported enrollment target (26% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02242201, a Phase 4 study of Total Hip Arthroplasty, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 165 participants
- Enrollment target
- 1
- Study location
Study Summary
Total hip arthroplasty is a one of the most commonly performed surgical procedures with increasing numbers anticipated over the next several decades. The purpose of this study was to find a better way to make patients comfortable after their hip surgery. Three different ways of providing pain relief were compared, a peripheral nerve block in the lower back outside of the spinal space (using bupivacaine, a numbing medicine), or injections around the hip joint with one of two different medicines, either Ropivacaine or Liposomal Bupivacaine (Exparel®).
Primary Outcome
Pain was measured on an ascending numeric rating scale (NRS) from 0-10 where 1-3 equaled mild pain, 4-6 equaled moderate pain, 7-9 equaled severe pain, and 10 equaled worst possible pain.
Conditions Studied
Interventions
- DRUG Ketorolac
- DRUG Epinephrine
- DRUG PNB Bupivacaine
- DRUG PAI Ropivacaine
- DRUG PAI liposomal bupivacaine
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-09 |
| Phase | Phase 4 |
What the finished NCT02242201 record still lists
NCT02242201 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, above the 131-participant average among 12 other Total Hip Arthroplasty trials with a reported enrollment target (26% higher).
The record links to 1 condition, with Total Hip Arthroplasty appearing as the primary indexed condition, and to 5 interventions - of which Ketorolac is the first listed.
NCT02242201 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02242201 about?
NCT02242201 is a clinical study titled "Total Hip Arthroplasty (THA) Lumbar Plexus Verses Periarticular". Total hip arthroplasty is a one of the most commonly performed surgical procedures with increasing numbers anticipated over the next several decades. The purpose of this study was to find a better way to make patients comfortable after their hip surgery. Three different ways of providing pain relief...
What is the current status of trial NCT02242201?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 165 participants. The study started on 2014-09. Estimated completion is 2016-09.
What conditions does trial NCT02242201 study?
This clinical trial studies the following conditions: Total Hip Arthroplasty.
What interventions are being tested in trial NCT02242201?
The interventions under investigation include: Ketorolac (DRUG), Epinephrine (DRUG), PNB Bupivacaine (DRUG), PAI Ropivacaine (DRUG), PAI liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT02242201?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02242201 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Hip Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02242201's enrollment target sits among peer trials
165 3rd of 12 higher than 10 of 12 other Total Hip Arthroplasty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Total Hip Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
RECRUITING · NA
-
Methadone in THA for Post-op Pain and Opioid Reduction
RECRUITING · Phase 3
-
Patient Utilization of Opioid Destruction Bags in the Post-op Period
ACTIVE NOT RECRUITING · NA
-
Strength and Function Following Total Hip Arthroplasty
COMPLETED · NA
-
Continuum™ Metal Bearing System in Total Hip Arthroplasty
COMPLETED
-
Improving Rehabilitation Outcomes After Total Hip Arthroplasty
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia